Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Even though targeted therapies are available for cancers expressing oncogenic epidermal growth receptor (EGFR) and (or) human EGFR2 (HER2), acquired or intrinsic resistance often confounds therapy success. |